Prompted by politicians and citizens, the federal Drug Enforcement Administration (DEA) is reassessing marijuana to determine if it should change the current drug classification. Presently, marijuana is classified as a Schedule I drug, like heroin and LSD, as a dangerous drug with "no currently accepted medical use and a high potential for abuse." In part due to scientific research, this may be changed to Schedule II, the same category as Ritalin, Adderal, and oxycodone prescriptions. This change in classification will ease restrictions for researchers to analyze marijuana for the essential compounds within it that help patients in pain. There are now significant barriers to researchers accessing marijuana for this research, delaying findings that could help create more marijuana-derived medications for patients. There is also only one supplier of medical marijuana for researchers currently, which could change if this new classification goes through.